Login / Signup

Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study.

Sandra Bohn ThomsenKristine Højgaard AllinJohan BurischCamilla Bjørn JensenSusanne HansenLise Lotte GluudKlaus TheedeMarianne Kiszka-KanowitzAnette Mertz NielsenTine Jess
Published in: United European gastroenterology journal (2019)
Our nationwide inflammatory bowel disease cohort study shows that concomitant thiopurine-allopurinol is as safe to use as thiopurines alone, with a tendency towards a positive effect on clinical outcomes in recent calendar periods when combined use was intended.
Keyphrases
  • patients with inflammatory bowel disease
  • cross sectional
  • combination therapy